Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Vasculitis Associated with Large Granular Lymphocytes Leukemia

Alexandra Audemard, MD student, Thierry Lamy, MD, PhD, Benoit Bareau, MD, Felipe Suarez, MD, PhD, Margaret Macro, MD, Loic Guillevin, MD, PhD, Flore Sicre, MD, Florence Truquet, Salaun Veronique, Jerome Rey, MD, Estibaliz Lazzaro, MD, PhD, Jonathan Boutemy, MD, Laurence Verneuil, MD, PhD, Stephane Cheze, Nicolas Schleinitz, MD, PhD, Thierry Lobbedez, MD, Loic Geffray, MD, Cindy Castrale, MD, Boris Bienvenu, MD, PhD

Blood (2012) 120 (21): 5109.

https://doi.org/10.1182/blood.V120.21.5109.5109

Published: 2012

Journal Articles

Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis

Domenico Sansonno, Felicia Anna Tucci, Laura Troiani, Gianfranco Lauletta, Michele Montrone, Vincenza Conteduca, Loredana Sansonno, Franco Dammacco

Blood (2008) 112 (5): 1620–1627.

https://doi.org/10.1182/blood-2008-02-137455

Published: 2008

Journal Articles

A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis.

Giovanni Barosi, MD, Elisabetta Gattoni, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD, Alessandro Rambaldi, MD, Lewis Silverman, MD, Judith Goldberg, MD, Roberto Marchioli, MD, Ronald Hoffman, MD

Blood (2007) 110 (11): 3540.

https://doi.org/10.1182/blood.V110.11.3540.3540

Published: 2007

Journal Articles

Bortezomid-Induced Sweet Syndrome.

Aline A. Schmidt-Tanguy, MD, Martine M. Avenel-Audran, MD, Séverine S. Lissandre, MD, Mammoun M. Dib, MD, Anne A. Croue, MD, Marie-Pierre M.P. Moles, MD, Norbert N. Ifrah, MD PhD, Mathilde M. Hunault-Berger, MD PhD

Blood (2006) 108 (11): 5128.

https://doi.org/10.1182/blood.V108.11.5128.5128

Published: 2006

Journal Articles

Drug-Induced Cutaneous Vasculitis in Patients with Non-Hodgkin’s Lymphoma Receiving Bortezomib: A Possible Surrogate Marker of Response.

John Gerecitano, MD, PhD, Andre Goy, MD, Barbara MacGregor-Cortelli, OCN, Ellen Neylon, John Wright, MD, PhD, Dixie Esseltine, MD, David Schenkein, MD, Mithat Gonen, PhD, Owen A. O’Connor, MD, PhD

Blood (2005) 106 (11): 3334.

https://doi.org/10.1182/blood.V106.11.3334.3334

Published: 2005

NARROW

Vasculitis Associated with Large Granular Lymphocytes Leukemia

Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis

A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis.

Bortezomid-Induced Sweet Syndrome.

Drug-Induced Cutaneous Vasculitis in Patients with Non-Hodgkin’s Lymphoma Receiving Bortezomib: A Possible Surrogate Marker of Response.

Email alerts

ASH Publications

American Society of Hematology

Vasculitis Associated with Large Granular Lymphocytes Leukemia

Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis

A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis.

Bortezomid-Induced Sweet Syndrome.

Drug-Induced Cutaneous Vasculitis in Patients with Non-Hodgkin’s Lymphoma Receiving Bortezomib: A Possible Surrogate Marker of Response.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only